High efficacy and tolerability of hepatitis C genotype 2 treatment with direct-acting antivirals in real world: analysis of the Hepa-C Registry
![Thumbnail](/dspace/bitstream/handle/2183/21636/Aranda_THU275.pdf.jpg?sequence=5&isAllowed=y)
View/ Open
Use this link to cite
http://hdl.handle.net/2183/21636
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 4.0
Collections
Metadata
Show full item recordTitle
High efficacy and tolerability of hepatitis C genotype 2 treatment with direct-acting antivirals in real world: analysis of the Hepa-C RegistryAuthor(s)
Date
2017Citation
Aranda EB, Mariño Z, Calvo S, et al. High efficacy and tolerability of hepatitis C genotype 2 treatment with direct-acting antivirals in real world: analysis of the Hepa-C Registry. En: Abstract of The International Liver Congress, 52nd Annual Meeting of the European Association for the Study of the Liver; 2017 Abr 19-23; Amsterdam. Amsterdam: Elsevier; 2017. p. S311 (Journal of Hepatology. 2017; 66 Suppl 1)
Description
Poster presentation
Editor version
Rights
Atribución-NoComercial-SinDerivadas 4.0
ISSN
0168-8278